Evidence map›Paper›PMID 17640696›Full record

ArticleVirology2007

Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay.

Suzanne Pontow, Brooke Harmon, Nancy Campbell, Lee Ratner

Open access · greenAbstract read
In one paragraph

Article in Virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Suzanne PontowDepartments of Medicine and Molecular Microbiology, Washington University School of Medicine, Box 8069, 660 S Euclid Ave, St. Louis, MO 63110, USA.
Brooke Harmon
Nancy Campbell
Lee Ratner
Washington University in St. Louis · US

Funding

Multicenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5M
PATHOGENESIS OF HUMAN IMMUNODEFICIENCY VIRUS INFECTIONR01AI024745 · NIAID · WASHINGTON UNIVERSITY · PI RATNER, LEE · 1987 to 2007
$1.5M
ZIDOVUDINE WITH PROBENECID--EFFECTS OF PROBENECID ON ZIDOVUDINEM01RR000722 · NCRR · JOHNS HOPKINS UNIVERSITY · 1985 to 1996
–
NCRR NIH HHS 5-M01-RR-00722NCRR NIH HHS M01 RR000722NIAID NIH HHS AI24745NIAID NIH HHS R01 AI024745NIAID NIH HHS U01 AI035042NIAID NIH HHS U01-AI-35042
6 · The paper itself

Abstract

A virus-dependent fusion assay was utilized to examine the activity of a panel of HIV-1, -2, and SIV isolates of distinct coreceptor phenotypes. This assay allowed identification of entry inhibitors, and characterization of an antagonist of a Rac guanine nucleotide exchange factor, as an inhibitor of HIV-mediated fusion.

Indexed as

Cell LineGuanine Nucleotide Exchange FactorsHIV-1HIV-2HIV Fusion InhibitorsHumansrac GTP-Binding ProteinsSimian Immunodeficiency VirusVirus InternalizationGuanine Nucleotide Exchange FactorsHIV Fusion Inhibitorsrac GTP-Binding Proteins

Identifiers

PMID17640696
PMCPMC2174213
OpenAlexW2087249906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.